Filter by:

Respiratory drug/device for the treatment of asthma & COPD

Rapid repair & recovery of acutely injured peripheral nerves

Oncology point-of-care diagnostics ($100M IPO in 2015)

Alzheimer’s therapeutics (sold to Allergan for $1B in 2016)

Ocular therapeutics (sold to Santen Pharma for $139M in 2011)

EXPLORE OUR LATEST NEWS & ARTICLES

INTERESTED IN THE LATEST FROM NEW RHEIN? VIEW OUR COMPANY NEWS, PRESS RELEASES & INDUSTRY ARTICLES.